Evidence map›Paper›PMID 40357670›Full record

ArticleJournal of diabetes science and technology2025

Assessing the Financial Sustainability of a Virtual Clinic Providing Comprehensive Diabetes Care.

Paul Dupenloup, Grace Guan, Grazia Aleppo, Richard M Bergenstal, Korey Hood, Davida Kruger, Teresa McArthur, Beth Olson, Sean Oser, Tamara Oser and 4 more

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paul DupenloupDepartment of Management Science and Engineering, Stanford University, Stanford, CA, USA.ORCID 0000-0003-2584-080X
Grace GuanDepartment of Management Science and Engineering, Stanford University, Stanford, CA, USA.ORCID 0000-0002-4904-6072
Grazia AleppoFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Richard M BergenstalInternational Diabetes Center, Minneapolis, MN, USA.ORCID 0000-0002-9050-5584
Korey HoodSchool of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0001-5730-7749
Davida KrugerHenry Ford Health System, Detroit, MI, USA.
Teresa McArthurCecelia Health, New York, NY, USA.
Beth OlsonLagoon Health, Minneapolis, MN, USA.
Sean OserSchool of Medicine, University of Colorado, Aurora, CO, USA.ORCID 0000-0002-9640-3087
Tamara OserSchool of Medicine, University of Colorado, Aurora, CO, USA.ORCID 0000-0002-0405-3420
Ruth S WeinstockSUNY Upstate Medical University, Syracuse, NY, USA.ORCID 0000-0001-5859-5666
Robin L GalJaeb Center for Health Research, Tampa, FL, USA.ORCID 0000-0002-9628-5383
Craig KollmanJaeb Center for Health Research, Tampa, FL, USA.
David ScheinkerDepartment of Management Science and Engineering, Stanford University, Stanford, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Virtual Diabetes Specialty Clinic (VDiSC) study demonstrated the feasibility of providing comprehensive diabetes care entirely virtually by combining virtual visits with continuous glucose monitoring support and remote patient monitoring (RPM). However, the financial sustainability of this model remains uncertain.

methodsWe developed a financial model to estimate the variable costs and revenues of virtual diabetes care, using visit data from the 234 VDiSC participants with type 1 or type 2 diabetes. Data included virtual visits with certified diabetes care and education specialists (CDCES), endocrinologists, and behavioral health services (BHS). The model estimated care utilization, variable costs, reimbursement revenue, gross profit, and gross profit margin per member, per month (PMPM) for privately insured, publicly insured, and overall clinic populations (75% privately insured). We performed two-way sensitivity analyses on key parameters.

resultsGross profit and gross profit margin PMPM (95% confidence interval) were estimated at $-4 ($-14.00 to $5.68) and -4% (-3% to -6%) for publicly insured patients; $267.26 ($256.59-$277.93) and 73% (58%-88%) for privately insured patients; and $199.41 ($58.43-$340.39) and 67% (32%-102%) for the overall clinic. Profits were primarily driven by CDCES visits and RPM. Results were sensitive to insurance mix, cost-to-charge ratio, and commercial-to-Medicare price ratio.

conclusionsVirtual diabetes care can be financially viable, although profitability relies on privately insured patients. The analysis excluded fixed costs of clinic infrastructure, and securing reimbursement may be challenging in practice. The financial model is adaptable to various care settings and can serve as a planning tool for virtual diabetes clinics.

Indexed as

continuous glucose monitoringdiabeteshealth economicsremote patient monitoringtelemedicine

Identifiers

PMID40357670
PMCPMC12075182

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.